Announcement under Regulation 30 (LODR)-Press Release / Media Release

We are enclosing herewith the press release relating to Financial Results for Q4FY25

Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication of Extract of Financial Results for the quarter and year ending 31st March 2025

Compliances-Reg.24(A)-Annual Secretarial Compliance

We are submitting the annual secretarial compliance report for the year ended 31st March 2025

Board Meeting Outcome for Outcome Of Board Meeting

Outcome of Board Meeting

Financial Results

Approved and Considered audited standalone and consolidated financial results for the quarter ended 31st March 2025

Board Meeting Intimation for Considering And Approving Standalone And Consolidated Quarterly Financial Results For The Period Ended 31St March 2025

Kilitch Drugs India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2025 inter alia to consider and approve Audited Standalone and Consolidated Financial Results for the quarter ended 31st March 2025

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

We are attaching herewith the certificate received from MUFG Intime India Private Limited the RTA of the Company

Reply To Query LODR Regarding Completion Of Tenure Of Independent Director

We herewith attached our reply

Announcement under Regulation 30 (LODR)-Retirement

We hereby inform you that Mr. Hemang Jagadish Engineer has completed his secon term as Independent Director of the Company on 31st March 2025

Closure of Trading Window

Trading Window for dealing in securities of the Company will remain closed for all the Designated Persons of the Company with effect from Tuesday 1st April 2025 till expiry of 48 hours after declaration of Financial Results of the Company

Intimation To Stock Exchange Regarding Report Submitted By Acquirer To The SEBI Under Regulation 10(

intimation to stock exchange regarding report submitted by acquirer to the SEBI under regulation 10(7) of SEBI SAST regulation

Announcement under Regulation 30 (LODR)-Newspaper Publication

We are submitting herewith the copy of extract of Notice of 32nd AGM published in the newspaper

Notice Of 32Nd Annual General Meeting

We are hereby submitting the Notice of 32nd Annual General Meeting of the Company to be held on 27th September 2024

Reg. 34 (1) Annual Report.

Pursuant to Regulations 34 of Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations 2015 we are submitting herewith the Annual Report for the Financial Year 2023-24

Intimation Of Book Closure

We hereby inform you that the Register of Members and Register of Share Transfer shall remain closed from Friday 20th September 2024 till Friday 27th September 2024 for the purpose of AGM

Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011

The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Mira Mehta

Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

Pursuant to Regulation 30 of SEBI LODR Regulation this is to inform you that the Board of Directors at their meeting held today appointed M/s Sharat & Associates Chartered Accountant as Statutory Auditors of the Company

Board Meeting Outcome for Outcome Of Board Meeting

Pursuant to Regulation 30 of SEBI LODR Regulations this is to inform you that the Board of Directors approved the appointment of M/s C Sharat & Company Chartered Accountants as a Statutory Auditors of the Company

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Mira Bhavin Mehta

Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Mira Bhavin Mehta

Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

Appointment of M/s. AVHP & Company LLP Chartered Accountant (FRN:W100671) as Statutory Auditors of the Company

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Issue of Duplicate Share certificate to S Mallikarjunappa

Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors

we hereby inform you that Suryaprakash Maurya co. Chartered Accountants statutory auditors of the Company have tendered their resignation vide letter dated 13th August 2024 informing their inability to continue as statutory auditor of the company with immediate effect.

Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulation

The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Mira Bhavin Mehta

Announcement under Regulation 30 (LODR)-Newspaper Publication

Submission of Newspaper Publication of extract of financial results for the quarter ended 30th June 2024

Submission Of Financial Results For The Quarter Ended 30Th June 2024

Submission of Standalone and Consolidated Results for the quarter ended 30th June 2024

Board Meeting Outcome for Submission Of Quarterly Standalone And Financial Results For The Quarter E

Submission of Quarterly Standalone and Financial Results for the quarter ended 30th June 2024

Board Meeting Intimation for Considering And Approval Of Unaudited Financial Results For The Period

KILITCH DRUGS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2024 inter alia to consider and approve unaudited financial results for the period ended 30th June 2024

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation of Issue of Duplicate share certificate to Shesappa Suvarna

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

Submission of Certificate under regulation 74(5) of SEBI (DP) Regulations.

Closure of Trading Window

Intimation of Closure of Trading window with effect from 1st July 2024 upto 48 hours from the declaration of unaudited results for the quarter and year ended 30th June 2024

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation of issue of duplicate share certificate to the shareholders detailed in the attached file

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation regarding loss of share certificate by the shareholders

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Submission of Transcript of Earning Call

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Audio recording of earning call

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

we hereby inform you that the Company will be hosting an investor and analyst conference call on Monday 10th June 2024 at 11:00 am to discuss the performance for the quarter and financial year ended 31st March 2024 as per the invite enclosed herewith

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation to the stock exchange regarding receipt of intimation of loss of share certificate by one of the shareholers

Financial Results For The Year Ended 31St March 2024

Financial Results for the year ended 31st March 2024

Board Meeting Outcome for Quarterly Financial Results For The Year Ended 31St March 2024

Quarterly financial results for the year ended 31st March 2024

Board Meeting Intimation for Audited Financial Results For The Quarter And Year Ended 31St March 202

KILITCH DRUGS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2024 inter alia to consider and approve financial results for the quarter and year ended 31st March 2024

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

We hereby inform that the company has received intimation regarding loss of share certificate by Narayan Shet N Verekar

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

We hereby inform you that the Company has issued duplicate share certificate to Mr. Manubhai Shah

Compliances-Reg.24(A)-Annual Secretarial Compliance

Please find enclosed herewith the annual secretarial compliance report for the financial year ended 31st March 2024

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation to stock exchanges regarding issuance of duplicate share certificate

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation to stock exchange regarding loss of share certificate by the shareholders

Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyKILITCH DRUGS (INDIA) LTD. 2CIN NO.L24239MH1992PLC066718 3 Outstanding borrowing of company as on 31st March / 31st December as... More> e (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No Name of the Company Secretary: Pushpa Nyoupane Designation: Company Secretary and Compliance Officer EmailId: pushpanyoupane?kilitch.com Name of the Chief Financial Officer: Sunil Jain Designation: Chief Financial Officer EmailId: suniljain?kilitch.com Date: 29/04/2024 Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. <Less

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation of Issue of Duplicate share certificate to shareholders. Details attached.

Certificate Under Regulation 40(10) Of SEBI(Listing Obligations And Disclosure Requirements) Regulat

Enclosing the certificate received from Practicing Company Secretary under regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulatitons 2015

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

Compliance Certificate under regulation 74(5) of SEBI (DP) Regulation 2018

Certificate Under Regulation 7(3) Of LODR For The Period Ended 31St March 2024

Compliance Certificate under regulation 7(3) of LODR for the period ended 31st March 2024

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation to the exchange regarding issue of Duplicate Certificate

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation received from Link Intime India Private Limited RTA of the Company regarding loss of share certificate by the shareholder

Closure of Trading Window

The trading window for dealing in securities of the Company will remain closed for all the designated person of the Company and their immediate relatives with effect from Monday 1st April 2024 till expiry of 48 hours after declaration of the financial results for the... More> uarter ended 31st March 2024<Less

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

We hereby inform you that we have received intimation from RTA regarding loss of share certificate by Ms. Nitaben Shah

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation regarding loss of share certificate as per intimation received from RTA

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation of issue of duplication share certificate to the shareholder upon intimation received from the Link Intime India Private Limited RTA of the Company

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation to stock exchanges regarding loss of share certificate by share holder

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation of Issuance of Duplicate Certificate

Announcement under Regulation 30 (LODR)-Press Release / Media Release

we are enclosing herewith the a press release relating to tender won by Kilitch Estro Biotech PLC subsidiary of the Company

Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015

We hereby inform you that the Kilitch Estro Biotech PLC subsidiary of the Company has won the tender issued by the Federal Democratic Republic of Ethiopia Pharmaceutical Supply Service

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation of Stop Transfer

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation of Loss of Share Certificate

Announcement under Regulation 30 (LODR)-Newspaper Publication

attaching herewith the copy of newspaper wherein the extract of the financial results for the quarter ended 31st December 2023 was published

Board Meeting Outcome for Financial Results For The Quarter Ended 31St December 2023

Submission of financial results for the quarter ended 31st December 2023

Financial Results For The Quarter Ended 31St December 2023

Declaration of Financial Results for the quarter ended 31st December 2023

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

We herby inform you that the Company has received intimation in with stop transfer due to loss of share certificate by shareholder as details attached from Link Intime India Private Limited RTA of the Company

Board Meeting Intimation for Considering And Approving The Unaudited Standalone And Consolidated Fi

KILITCH DRUGS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2024 inter alia to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 31st December 2023

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

We hereby attaching the details regarding issue of duplicate share certificate